
SC Launch Inc. invests in Leukogene Therapeutics
Columbia, SC—SC Launch Inc., the investment affiliate of the South Carolina Research Authority, has invested in Leukogene Therapeutics. The Charleston-based biotechnology startup is developing a pipeline of targeted immunotherapies for patients with advanced cancers. “This investment will enable Leukogene to accelerate the development of its innovative pipeline, advance key preclinical and early clinical milestones, and […]




























































































































































